op-3136
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
Olema Pharmaceuticals, Inc.Phase 1
—
Rating in progress
op-3136 in Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active